Insulet (PODD) Liabilities from Discontinued Operations (2015)

Insulet's (PODD) quarterly Liabilities from Discontinued Operations came in at 5319000.0 in Q4 2015.

Insulet (PODD) Liabilities from Discontinued Operations (2015) Analysis & Trends

Insulet (PODD) has 1 years of Liabilities from Discontinued Operations data on file, last reported at 5319000.0 in Q4 2015.

Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 5319000.0 in Q4 2015, while the trailing twelve-month figure through Dec 2015 was 5319000.0 (changed N/A YoY) and the FY2015 annual result came in at 5319000.0, changed N/A from the prior year.
Liabilities from Discontinued Operations held at 5319000.0 in Q4 2015.
In the past five years, Liabilities from Discontinued Operations ranged from a high of 5319000.0 in Q4 2015 to a low of 5319000.0 in Q4 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn
10	Insulet	10.27 Bn	9.74 Bn	562.60 Mn

Download Data

Date	Value
Dec 31, 2015	5.32 Mn
Dec 31, 2015	5.32 Mn